The inconsistency of JNK inhibitors has been attributed to both the lack of a sufficient degree of selectivity of these compounds for JNK [14] and involvement of the JNK signaling pathway not only in MI pathogenesis but also in the chain of compensatory and protective reactions occurring in the myocardium after I/R [15,24]. This evidence concerns the gene MAPK8 and myocardial infarction.